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Introduction
Recent reviews regarding the role of 
 environmental risk factors in adult-onset 
asthma showed that occupational expo-
sures are important causes of asthma in 
adults (Le Moual et al. 2013; Beasley et al. 
2015). Approximately 15% of adult asthma 
is likely to be attributable to occupational 
exposures (Torén and Blanc 2009), and 
occupational asthma is known to be a good 
model for studying the pathophysiology 
of asthma in general (Malo et al. 2015). 
Exposure to cleaning agents is an emerging 
risk factor for adult-onset asthma. Evidence 
of adverse effects of cleaning products and 
disinfectants in asthma mostly comes from 
studies on occupational risk factors (Siracusa 
et al. 2013), but a deleterious role has also 
been observed for domestic cleaning exposure 
(Quinn et al. 2015; Le Moual et al. 2013; 
Dumas et al. 2013). Some of the numerous 
agents contained in cleaning products and 
disinfectants are chemical sensitizers, but 
most are hypothesized to act as respiratory 
irritants (Siracusa et al. 2013). The biological 
mechanisms by which cleaning products and 
disinfectants affect respiratory health remain 
incompletely evaluated (Tarlo and Lemiere 
2014; Le Moual et al. 2013; Tarlo 2014). 
However, inhalation of low molecular weight 
(LMW) agents and irritants is likely to induce 
the release of reactive oxygen species through 
the epithelium, and oxidative stress is known 
to be a potential mechanism of epithelium 
injury (Mittal et al. 2014). Furthermore, 
there is strong evidence that an imbalance 
between the reducing and oxidizing systems 
favoring the oxidative state is present in 
asthma. Reactive oxygen and nitrogen species 
from endogenous and exogenous sources 
play major roles in airway inflammation, 
and oxidative stress is an important patho-
physiological component of asthma (Chung 
and Marwick 2010; Aldakheel et al. 2016). 
Thus, to better understand the mechanism by 
which LMW chemical sensitizers and irritants 
are related to asthma, it may be particularly 
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Background: The biological mechanisms by which cleaning products and disinfectants—an 
emerging risk factor—affect respiratory health remain incompletely evaluated. Studying genes by 
environment interactions (G × E) may help identify new genes related to adult-onset asthma.
oBjectives: We identified interactions between genetic polymorphisms of a large set of genes 
involved in the response to oxidative stress and occupational exposures to low molecular weight 
(LMW) agents or irritants on adult-onset asthma.
Methods: Our data came from three large European cohorts: Epidemiological Family-based Study 
of the Genetics and Environment of Asthma (EGEA), Swiss Cohort Study on Air Pollution and 
Lung and Heart Disease in Adults (SAPALDIA), and European Community Respiratory Health 
Survey in Adults (ECRHS). A candidate pathway–based strategy identified 163 genes involved 
in the response to oxidative stress and potentially related to exposures to LMW agents/irritants. 
Occupational exposures were evaluated using an asthma job-exposure matrix and job-specific ques-
tionnaires for cleaners and healthcare workers. Logistic regression models were used to detect G × E 
interactions, adjusted for age, sex, and population ancestry, in 2,599 adults (mean age, 47 years; 
60% women, 36% exposed, 18% asthmatics). p-Values were corrected for multiple comparisons.
results: Ever exposure to LMW agents/irritants was associated with current adult-onset asthma 
[OR = 1.28 (95% CI: 1.04, 1.58)]. Eight single nucleotide polymorphism (SNP) by exposure inter-
actions at five loci were found at p < 0.005: PLA2G4A (rs932476, chromosome 1), near PLA2R1 
(rs2667026, chromosome 2), near RELA (rs931127, rs7949980, chromosome 11), PRKD1 
(rs1958980, rs11847351, rs1958987, chromosome 14), and PRKCA (rs6504453, chromosome 17). 
Results were consistent across the three studies and after accounting for smoking.
conclusions: Using a pathway-based selection process, we identified novel genes potentially 
involved in adult asthma by interaction with occupational exposure. These genes play a role in the 
NF-κB pathway, which is involved in inflammation.
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relevant to focus on the oxidative pathway 
(Tarlo and Lemiere 2014; Tarlo 2014).
Asthma is a heterogeneous disease, and 
it is now well established that it is caused by 
a complex interplay of environmental and 
genetic factors (Kauffmann and Demenais 
2012). Considerable efforts have been made 
to characterize the genetic determinants of 
asthma (Holloway et al. 2010); however, the 
identified genetic factors explain only a small 
part of the genetic component of asthma. One 
reason for this lack of understanding is that 
many genetic factors are likely to be involved 
in the development, activity, and severity of 
asthma, and that these factors act primarily 
through complex mechanisms that involve 
inter actions with environmental factors (G × E) 
and with other genes (G × G), notably through 
pathways and networks. Furthermore, the 
effects of such genetic factors may be missed 
if genes are considered individually, regard-
less of the biological functions they share with 
other genes or the pathways in which they are 
involved (Liu et al. 2012). Candidate G × E 
inter action studies conducted on genes involved 
in the response to oxidative/ nitrosative stress 
and their interaction with environmental 
exposures in asthma focused more on children 
than on adults and mostly focused on outdoor 
air pollution and smoking (Romieu et al. 
2010; Minelli et al. 2011). Furthermore, 
these studies have explored a limited number 
of genes (Kauffmann and Demenais 2012; 
Kogevinas 2014; Rava et al. 2015). To increase 
the number of genes to be investigated, we 
recently proposed a candidate pathway–based 
strategy to select an enriched gene set for 
G × E interaction studies (Rava et al. 2013). 
This gene selection process integrates infor-
mation on the biological processes shared by 
genes, the canonical pathways to which genes 
belong, and the biological knowledge related 
to the environmental exposure under study. 
This approach represents a powerful alternative 
strategy between genome-wide and candidate 
approaches to detect relevant associations of 
environmental exposures with biological 
markers as well as G × E interactions.
In the present paper, we hypothesized that 
genes involved in the response to oxidative 
stress modify the associations of exposure to 
LMW agents and irritants with current asthma. 
We first applied the candidate pathway–based 
strategy to select oxidative stress–related genes 
that may interact with occupational exposures 
to LMW agents and irritants in current adult-
onset asthma. We then tested for interactive 
effects of single nucleotide polymorphisms 
(SNPs) of these genes and LMW agents and 
irritants on current adult-onset asthma in 2,599 
participants from the French Epidemiological 
family-based study of the Genetics and 
Environment of Asthma (EGEA), the Swiss 
Cohort Study on Air Pollution and Lung and 
Heart Disease in Adults (SAPALDIA), and 
the European Community Respiratory Health 
Survey (ECRHS).
Methods
Study Population
Our data came from three multicenter 
epidemiological European studies: EGEA 
(Kauffmann et al. 1997; Kennedy et al. 2000) 
(see Figure S1A) and two population-based 
studies, SAPALDIA (Downs et al. 2007; 
Mehta et al. 2012; Ackermann-Liebrich et al. 
2005) (see Figure S1B) and ECRHS (ECRHS 
2002; Kogevinas et al. 2007) (see Figure S1C). 
All three cohorts used comparable study 
designs and highly comparable question-
naires. Participants included in the analyses 
were derived from the entire study population 
for EGEA and from the nested case–control 
samples within the ECRHS (Smit et al. 2014) 
and SAPALDIA cohorts (Curjuric et al. 
2012). Participants had genome-wide SNP 
data; occupational history regarding LMW 
agents and irritants, particularly cleaning/
disinfecting products; and data on adult-onset 
asthma and relevant covariates such as age, sex, 
and smoking status.
Ethical approval was obtained for each 
study from the appropriate institutional ethics 
committees, and written informed consent was 
obtained from each participant. Detailed cohort 
descriptions are given in the Supplemental 
Material, “Description of the three multicentre 
epidemiological European studies.”
Current Adult-Onset Asthma
In all cohorts, current asthma was defined as 
ever diagnosis of asthma (Moffatt et al. 2010; 
Smit et al. 2014) and presence of respiratory 
symptoms (wheeze; nocturnal chest tight-
ness; attacks of breathlessness after activity, 
at rest, or at night; asthma attacks) or using 
asthma medications in the last 12 months. 
Participants without asthma were those 
without asthma at baseline and at follow-up. 
Participants with ever asthma but without 
symptoms or treatment in the last 12 months 
were excluded. Because we were interested 
in participants who may have developed 
asthma because of occupational exposure, 
we restricted the current adult-onset asthma 
definition to asthmatics with an age of onset 
≥ 16 years old.
Occupational Exposures to LMW 
Agents and Irritants
In all cohorts, occupational history was 
recorded by interview, and job codes were 
linked to an asthma-specific job-exposure 
matrix (JEM) evaluating exposure to 22 
agents and including a local expert reevalua-
tion step (Kennedy et al. 2000). Healthcare 
workers and cleaners were further asked to 
answer a job-specific questionnaire regarding 
exposure to cleaning/disinfecting products.
In the present study, we considered only 
exposures to substances hypothesized to cause 
irritant-asthma or to cause asthma through 
mechanisms induced by LMW agents. 
Exposure to LMW agents was evaluated by 
the JEM and included not only products typi-
cally classified as LMW agents (e.g., highly 
reactive chemicals, metals) but also mixed 
environments with potential exposure to 
high molecular weight (HMW) and LMW 
agents (e.g., agriculture, textiles). Exposure to 
irritants was evaluated using a) the JEM, for 
high-peak irritant exposure, and b) self-reported 
exposure to cleaning/disinfecting products, 
with a focus on those with a greater likelihood 
of being respiratory irritants (see Table S1 
for more details). Participants who had ever 
been exposed to any of the LMW agents, 
mixed environments, irritants, or any specific 
cleaning/disinfecting products were classified as 
“exposed.” Unexposed participants were those 
who were never exposed to any of the 22 agents 
of the asthma JEM (including HMW agents) 
or to other potential risk agents for respiratory 
health (vapors, general dusts, gases, and fumes) 
evaluated by another JEM (ALOHA JEM) 
(Matheson et al. 2005; de Jong et al. 2015). All 
three cohorts used the same definitions.
Genotyping
The three cohorts (EGEA, SAPALDIA, and 
ECRHS) were part of the European Gabriel 
consortium (http://cordis.europa.eu/project/
rcn/84712_en.html) for asthma genetics 
(Moffatt et al. 2010) and constitute the ESE 
consortium. Participants were genotyped 
using the Illumina 610 Quad array (Illumina, 
San Diego, CA) at the Centre National de 
Génotypage (CNG; Evry, France). Stringent 
quality criteria, as detailed by Imboden et al. 
(2012), were used to select both individuals 
and SNPs for analysis. The quality control 
(QC) criteria were call rate ≥ 97%, minor 
allele frequency ≥ 5%, and Hardy–Weinberg 
(HW) p-value > 10–4.
Gene coverage, which indicates the fraction 
of common HapMap markers successfully 
tagged by the set of selected SNPs, was obtained 
using Haploview 4.2 (Barrett et al. 2005). 
We specified that all HapMap markers being 
captured by the set of tags should be correlated 
at r2 ≥ 0.8 with at least one marker in the set.
Gene Selection Through a 
Candidate Pathway–Based Strategy
For this study, a large set of genes was selected 
according to a previously published candi-
date pathway–based strategy (Rava et al. 
2013). Briefly, the selection process followed 
three steps.
Step 1: Gene selection. We used the Gene 
Ontology (GO) database [Gene Ontology 
Candidate genes and occupational exposures in asthma
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Consortium (Ashburner et al. 2000; http://
amigo2.berkeleybop.org/amigo, version 1.8)] 
to select genes involved in the response to 
oxidative stress (GO:0006979). This list 
was further enlarged by literature reviews 
of asthma-related genome-wide association 
studies and biological studies on response 
to oxidative stress related to environmental 
exposures of interest.
Step 2: Pathway enrichment. Using 
Ingenuity Pathway Analysis (IPA; http://www.
ingenuity.com/), we identified the canonical 
pathways that contained ≥ 5 genes out of the 
set of the genes selected in Step 1 and that were 
significantly enriched in these genes (p < 0.05).
Step 3: Environment integration. We 
selected the subset of pathways identified at 
Step 2 that contained genes selected at Step 
1 expected to be involved in the response to 
oxidative stress potentially caused by occupa-
tional exposure to LMW agents or irritants. 
This strategy has been fully detailed by Rava 
et al. (2013).
For each of the genes belonging to the 
selected pathways, we examined all SNPs 
passing the QC process and lying from 20 kb 
upstream to 20 kb downstream of the gene 
[UCSC genome browser hg18 assembly, 
build 37.1 (Kent et al. 2002; https://genome.
ucsc.edu/)]).
Statistical Analysis Strategy
The three ESE cohorts were pooled to increase 
statistical power as before (Smit et al. 2012, 
2014); this strategy also allowed us to assess 
the consistency of the results across cohorts. 
SNP–occupational exposure interactions 
were investigated using a logistic regression 
model that included the SNP effect assumed 
to be additive, a binary exposure (E) variable 
(1 = exposed, 0 = unexposed), and a multi-
plicative term for SNP × E interaction. All 
models were adjusted for age, sex, and the four 
first principal components (PCs) to account 
for population stratification as was done 
previously (Smit et al. 2014). No additional 
adjustments were made for study because 
PCs capture any possible variability caused 
by geographical location. Smoking status was 
further included as a potential confounder.
The test of SNP × E interaction was based 
on a Wald test. To account for multiple testing, 
the Benjamini–Hochberg (1995) procedure 
was implemented. For interactions belonging 
to the top 1% of p-value distributions, the 
consistency of interaction effect estimates across 
studies was assessed using Cochran’s Q test, 
and the extent of heterogeneity was measured 
using I2, which ranges from 0% to 100%. The 
I2 statistic describes the percentage of variation 
across studies that is due to heterogeneity rather 
than to chance (Higgins and Thompson 2002; 
Higgins et al. 2003); I2 = 100% × (Q-degree 
of freedom)/Q. I2 values of 0–24% suggest 
little heterogeneity; values of 25–49% reflect 
moderate heterogeneity; values of 50–74% 
reflect large heterogeneity; and I2values > 75% 
reflect very large heterogeneity (Viechtbauer 
and Cheung 2010). Because smoking may also 
induce oxidative stress, a sensitivity analysis 
excluding current smokers was performed. The 
robustness of the results to the family depen-
dency existing in the EGEA study was inves-
tigated using generalized estimating equations 
(GEE) with an exchangeable working corre-
lation matrix to take into account potential 
clustering within families.
For each of the genes belonging to the 
selected pathways, interactions with occupa-
tional exposure for current adult-onset asthma 
were also investigated at the gene level using 
the versatile gene-based test (VEGAS; Liu 
et al. 2010). This gene-based statistic sums up 
the χ2 test statistics of SNP × E interactions 
(square of the Wald test statistics) for all SNPs 
of a gene. The correlation (r2) between these 
statistics is taken into account by computing 
an empirical p-value through Monte Carlo 
simulations using the linkage disequilibrium 
pattern of HapMap Utah residents with 
ancestry from northern and western Europe 
(CEU) reference sample; this empirical p-value 
is estimated by the proportion of simulated 
test statistics that exceeds the observed gene-
based test statistic. The empirical p-values were 
then adjusted for multiple testing using the 
method of Benjamini and Hochberg (1995).
Expression Quantitative Trait Loci 
Analysis, Functional Annotation and 
Chemical–Gene/Protein Interactions
We investigated whether the SNPs (or their 
proxies, r2 ≥ 0.8) found to interact with occu-
pational exposures to LMW agents or irritants 
were cis-expression quantitative trait loci (cis-
eQTLs). We used the eQTL browser (http://
www.gtexportal.org/home/), which includes 
eQTL data from many tissues from the 
Genotype–Tissue Expression project (GTEx) 
(Gibson 2015). Furthermore, functional anno-
tations of these SNPs (or proxies) were made 
using the HaploReg tool (http://www.broadin 
stitute.org/mammals/haploreg/haploreg.
php). HaploReg annotates SNPs in terms of 
predicted ROADMAP and ENCyclopedia Of 
DNA Elements (ENCODE), chromatin states 
(promoter and enhancer histone modifica-
tion signals), DNase I hypersensitivity sites, 
and transcription factor (TF) and protein 
binding sites.
Furthermore, curated (chemical–gene 
interactions/chemical–disease/gene–disease) 
data were retrieved from the Comparative 
Toxicogenomics Database (CTD; http://
ctdbase.org/; Davis et al. 2015; MDI 
Biological Laboratory, Salisbury Cove, Maine, 
and North Carolina State University, Raleigh, 
North Carolina). CTD is a robust, publicly 
available database that aims to advance under-
standing about how environmental exposures 
affect human health. It provides manually 
curated information about chemical–gene/
protein interactions and chemical–disease and 
gene–disease relationships.
Results
Data Description
The study population included 2,599 partici-
pants with a mean age of 46.7 years and 60% 
women (Table 1). ECRHS participants were 
younger than SAPALDIA and EGEA partici-
pants, and the proportion of women was lower 
in SAPALDIA. Almost half of the participants 
were never smokers. The proportion of current 
smokers varied from 18.6% (EGEA) to 31.4% 
(ECRHS), and 463 had current adult-onset 
asthma. Among the 927 exposed participants, 
25.4% were exposed to LMW agents only, 
4.4% were exposed to irritants only, 23.7% 
were health care workers or cleaners (exposure 
to cleaning products), 12.6% were exposed 
to mixed environment only, and 33.9% had 
combined exposures (i.e., two or more of the 
aforementioned exposures).
A positive and significant association 
was found between lifetime occupational 
exposure to LMW agents or irritants and 
current adult-onset asthma: age- and sex-
adjusted pooled Odds Ratio (ORa) = 1.28; 
Table 1. Characteristics of adult participants in the three studies.
Characteristic
All 
(n = 2,599)
ECRHS 
(n = 1,336)
SAPALDIA 
(n = 574)
EGEA 
(n = 689)
Age, year, mean (SD) 46.7 (11.3) 43.1 (7.1) 53.4 (10.9) 48.0 (14.9)
Sex, women, n (%) 1,563 (60.1) 822 (61.5) 311 (54.2) 430 (62.4)
Smoking habits, n (%)
Never smokers 1,167 (44.9) 569 (42.6) 248 (43.2) 350 (50.8)
Former smokers 735 (28.3) 337 (25.2) 191 (33.3) 207 (30.0)
Current smokers 682 (26.2) 419 (31.4) 135 (23.5) 128 (18.6)
Missing 15 (0.6) 11 (0.8) 0 (0.0) 4 (0.6)
Occupational exposure, n (%)a 927 (35.7) 440 (32.9) 175 (30.5) 312 (45.3)
Current adult-onset asthma, n (%) 463 (17.8) 234 (17.5) 107 (18.6) 122 (17.7)
Notes: ECHRS, European Community Respiratory Health Survey; EGEA, Epidemiological family-based study of the Genetics 
and Environment of Asthma; SAPALDIA, Swiss Cohort Study on Air Pollution and Lung and Heart Disease in Adults.
aPercent ever exposed to low molecular weight agents or to mixed environments or to high-peak irritants, or to specific 
cleaning products or disinfectants in the population selected for the analyses, that is to say, after excluding adults with 
occupational exposures to other potentially asthmagenic agents (high molecular weight agents).
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[95% confidence interval (CI): 1.04, 1.58]. 
Across the three cohorts, the associations 
between exposure and asthma were as follows: 
age- and sex-adjusted ORa = 1.09 (95% CI: 
0.72, 1.65; n = 122/689, cases/all) in EGEA, 
0.89 (95% CI: 0.56, 1.42; n = 107/574) in 
SAPALDIA, and 1.55 (95% CI: 1.15, 2.08; 
n = 234/1,336) in ECRHS.
Genes Selected with the Candidate 
Pathway–Based Strategy
Step 1: Gene selection. A total of 387 genes 
were selected through GO and further 
enriched by literature reviews and biological 
studies to obtain a list of 411 genes.
Step 2: Pathway enrichment. We identi-
fied 277 pathways that contained ≥ 5 genes 
out of the 411 genes selected at step 1 and 
were enriched in these genes (p < 0.05).
Step 3:  Environment integration. 
Seventeen of the 277 pathways were further 
selected because they included genes involved 
in responding to oxidative stress and were 
potentially related to exposures to LMW 
agents or irritants. These pathways had 
pathway enrichment p-values ranging from 
0.03 to 1.58 × 10–31 (see Excel File Table S1) 
and included 5–47 genes (15–20 genes on 
average); > 50% of the genes were involved 
in more than one pathway. The final analyzed 
set included a total of 163 unique genes (see 
Excel File Table S2) and 3,297 SNPs.
Analysis of SNPs × Occupational 
Exposure Interactions
At the SNP level, none of the inter actions 
with LMW/irritants on current adult-
onset asthma reached the level of signifi-
cance after correction for multiple testing 
(p = 0.05/3,297 = 1.5 × 10–5). However, 
we selected 14 interactions belonging to the 
top 1% of the p-value distribution ranked 
from lowest (top) to highest (bottom) (see 
Table S2). Among these 14 inter actions, 
8 interactions at 5 loci showed little hetero-
geneity (I2 < 24%) between the three studies 
(Table 2; see also Table S3): rs932476 in 
PLA2G4A [phospholipase A2, group IVA 
(cytosolic, calcium-dependent) gene, chromo-
some 11, p = 0.005]; rs2667026 near PLA2R1 
(phospholipase A2 receptor 1, chromosome 
2, p = 0.005); rs931127 and rs7949980 near 
RELA (v-rel avian reticuloendotheliosis viral 
oncogene homolog A gene; chromosome 
11; p = 0.001 and p = 0.003, respectively), 
rs1958980, rs11847351, and rs1958987 in 
PRKD1 (protein kinase D1, chromosome 14, 
p-values ranging from 0.004 to 0.005); and 
rs6504453 in PRKCA (protein kinase C alpha, 
chromosome 17, p = 0.003). The two SNPs 
near RELA were in moderate linkage disequi-
librium (LD; r2 = 0.65), whereas the three 
SNPs in PRKD1 were in strong LD (r2 > 0.8; 
see Figure S2A–E). Further, rs932476 in 
PLA2G4A and rs931127 in RELA were also 
marginally associated with asthma (p = 0.0036 
and p = 0.035, respectively, Table 2). Similar 
interactive and marginal estimates were 
obtained by taking into account family depen-
dency (see Table S4) or by adjusting for study/
center (data not shown). Excluding current 
smokers from the analysis showed consistent 
results except for PLA2G4A (see Table S4). 
Finally, adjusting for smoking gave similar esti-
mates (see Table S4).
Associations between SNPs and current 
adult-onset asthma in unexposed and exposed 
participants are reported in Figure 1. “Flip-
flop” interactions were observed. Near RELA, 
the risk of current adult-onset asthma was 
increased in G carriers of rs931127 and in 
T carriers of rs7949980 among exposed 
participants (OR = 1.54, p = 2 × 10–4 and 
OR = 1.40, p = 0.005, respectively), whereas 
inverse but non-significant effects were 
observed among unexposed participants. 
The risk was also increased—although not 
statistically significant—among exposed 
participants for G carriers of rs2667042 
near PLA2R1, whereas inverse and signifi-
cant effects (OR = 0.74, p = 0.009) were 
observed among unexposed participants. On 
the contrary, the risk of current adult-onset 
asthma was decreased, but not significantly 
so, among exposed participants for G carriers 
of rs932476 in PLA2G4A; for G carriers of 
rs1958980, G carriers of rs11847351, or T 
carriers of rs1958987 in PRKD1; and for T 
carriers of rs6504453 in PRKCA; the risk 
was decreased significantly for T carriers of 
rs6504453 in PRKCA (OR = 0.79, p = 0.05), 
whereas inverse and significant effects were 
observed among unexposed participants 
(OR = 1.25 to 1.50, p = 0.01 to 3 × 10–4).
PRKD1 and PRKCA are involved together 
in the NRF2-mediated oxidative stress 
response pathway; in association with RELA 
in three other pathways: xenobiotic metabo-
lism signaling, production of nitric oxide and 
reactive oxygen species in macrophages, and 
N-formyl-methionine-leucyl-phenylalanine 
(fMLP) signaling in neutrophils; and in asso-
ciation with PLA2G4A in CCR3 signaling 
in eosinophils (see Excel File Table S3). 
Furthermore,  RELA  and PRKCA  are 
involved together in apoptosis signaling, 
and RELA, PLA2G4A, and PLA2R1 are 
involved together in the antioxidant action of 
vitamin C pathway.
Gene coverage for the SNPs in PLA2G4A, 
PLA2R1, PRKD1, and PRKCA was quite 
high: 55% (r2 = 0.98), 76% (r2 = 0.97), 74% 
(r2 = 0.96) and 68% (r2 = 0.96), respectively. 
Low coverage was observed for RELA (< 10%).
Analysis of Gene × Occupational 
Exposure Interactions
At the gene level, RELA and PRKD1 were 
among the top gene interactions with occupa-
tional exposures to LMW/irritants that were 
detected by the gene-based test among all 163 
studied genes (p-value = 0.009 and p = 0.04, 
respectively; see Table S5), but none reached 
significance after correction for multiple testing.
eQTL, Functional Annotations and 
Chemical–Gene/Protein Interactions
Using the eQTL browser GTEx, we found 
that the T allele at rs6504453 in PRKCA 
was associated with increased gene expres-
sion in lung tissue (see Figure S3, p = 0.017). 
No eQTL was found among the SNPs 
(or proxies) interacting with exposures at 
PLA2G4A, PLA2R1, RELA and PRKD1 loci.
Using the functional annotation tool 
HaploReg v3, we found that the SNPs 
rs932476 in PLA2G4A, rs2667026 near 
PLA2R1, rs931127 and rs7949980 near 
RELA, and rs1958980, rs11847351, and 
rs1958987 in PRKD1 mapped to marks in 
active regulatory elements, notably in B cells, 
small airway epithelial cells, and lymphoblas-
toid cell lines. These marks included enhancer 
histone marks, DNase hypersensitivity sites, 
and binding protein sites for NF-κB, histone 
deacetylase 2 (HDAC2), and nuclear factor 
erythroid 2-related factor 2 (Nrf2) (see Excel 
File Table S4).
Table 2. Interactive effects of single nucleotide polymorphisms with occupational exposure to low 
molecular weight agents or irritants on current adult-onset asthma.
Chr Gene SNP
Reference/
effect allele EAFa
Cases/controls 
n/n
Marginal effect Interaction–CC
OR p-Value OR p-Value
1 PLA2G4A rs932476 A/G 0.35 463/2,136 1.25 0.0036 0.64 0.0050
2 PLA2R1 rs2667026 A/G 0.83 463/2,136 0.89 0.2354 1.77 0.0050
11 RELAb rs931127 A/G 0.43 462/2,135 1.17 0.0350 1.61 0.0014
11 RELA rs7949980 C/T 0.51 463/2,133 1.07 0.3421 1.56 0.0030
14 PRKD1b rs1958980 A/G 0.67 463/2,136 1.08 0.3344 0.64 0.0042
14 PRKD1 rs11847351 A/G 0.67 463/2,133 1.08 0.3429 0.64 0.0043
14 PRKD1 rs1958987 C/T 0.68 459/2,127 1.07 0.3609 0.64 0.0050
17 PRKCA rs6504453 C/T 0.35 462/2,134 1.04 0.6086 0.63 0.0032
Notes: CC, case–control; Chr, chromosome; EAF, effect allele frequency; OR, odds ratio; SNP, single nucleotide 
polymorphism. 
aCalculated in controls.
bThe two SNPs near RELA are in moderate linkage disequilibrium (LD) with r 2 = 0.65, whereas the three SNPs in PRKD1 
are in strong LD (r 2 > 0.8).
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Further, from the CTD (http://ctdbase.
org/; Davis et al. 2015; MDI Biological 
Laboratory, Salisbury Cove, Maine, and 
North Carolina State University, Raleigh, 
North Carolina), we found that chlorine, 
formaldehyde, and hydrogen peroxide have 
been reported to modify the localization of 
PRKCA protein, the expression of PLA2R1 
and PLA2G4A mRNA, and the expression 
and activity of RELA protein (see Excel File 
Table S5). We also found that exposures 
known to contain compounds with irritant 
properties (air pollutants and vehicle emis-
sions) modified the expression of PRKD1 
mRNA and the methylation of PLA2R1 (see 
Excel File Table S5).
Discussion
This study identified interactions between 
genetic variants near or within five genes, 
PLA2G4A, PLA2R1, RELA, PRKD1 and 
PRKCA, and occupational exposures to LMW 
agents or irritants for current adult-onset 
asthma. The evidence for these interactions lies 
in the results obtained from the pooled data of 
three large European epidemiological studies 
and the consistency of the results across 
these studies. Functional annotations of the 
interacting SNPs at these loci and functional 
supports specific for the G × E inter actions 
detected suggest that a few of these SNPs 
might be involved in regulatory mechanisms.
Until now, a limited number of genes 
were explored in G × E interaction studies 
conducted with candidate gene approaches. 
The most commonly studied genes were those 
coding for the enzymes NAD(P)H dehydro-
genase [quinine] 1 (NQO1), the glutathione 
S-transferases (GSTs), heme oxygenase 1 
(HMOX-1), catalase (CAT) and superoxide 
dismutase (SOD) (Minelli et al. 2011). 
Our study relied on an original strategy to 
select and enlarge the list of candidate genes. 
Because it is supported by biological knowl-
edge, this approach allows a good tradeoff 
between genome-wide interaction studies 
(GEWIS) and candidate gene approaches. 
It is interesting to note that our set of 163 
genes included the few genes mentioned 
previously and studied in interaction with 
other exposures related to oxidative stress 
(smoking, outdoor air pollution) in asthma 
following a candidate gene approach. We 
cannot exclude that our selection may have 
overrepresented the antioxidative defense 
and may have lost a number of relevant 
genes that were not targeted by our analysis. 
However, we were able to highlight that 
genes modulating exposure to LMW agents 
and irritants all have a prominent role in 
the NF-κB pathway, and our strategy also 
has the capacity to generate new hypoth-
eses. One of the difficulties in G × E studies 
is the need for large studies or consortia to 
detect significant interaction, which in turn 
might be affected by heterogeneity in both 
the outcomes and the exposure definitions 
of the participating studies. To overcome 
these limitations, the definition of adult-
onset asthma as well as those of occupational 
exposures to LMW agents or irritants were 
harmonized across the three epidemiological 
studies, and genotyping was performed iden-
tically in the three studies in the framework 
of the European Gabriel consortium asthma 
GWAS (Moffatt et al. 2010). Despite the 
fact that the three studies were pooled, we 
obtained 463 exposed participants with adult-
onset asthma to detect G × E inter actions. 
This small number of exposed cases may have 
hampered our findings, and we acknowledge 
that the lack of replication is a limitation. 
However, replication is very difficult because 
EGEA, SAPALDIA, and ECRHS are, to 
the best of our knowledge, the only three 
cohorts having such specific information on 
occupational exposures (the asthma-specific 
JEM with the expertise step that increases the 
precision of the exposure assessment and the 
specific questionnaires for cleaners and health 
care workers). By adding other studies using 
only the asthma-specific JEM, we would lose 
part of the specificity of our analysis. None 
of our G × E interaction tests reached the 
significance level after correction for multiple 
testing, so we focused on SNPs with p-values 
for SNPs × E in the top 1% of the distribu-
tion, and we reduced false positives by only 
selecting consistent interactions across the 
three studies. With regard to the method 
used, various study designs and statistical 
methods have been proposed to investigate 
G × E inter actions (Liu et al. 2012). We used 
the classical G × E interaction test based on 
a case–control design, which may not be the 
most powerful approach. Indeed, when one 
can assume independence between exposure 
and SNPs, it has been shown that case-only–
based approaches (Mukherjee et al. 2008) are 
better alternatives. However, these approaches 
Figure 1. Associations between SNPs that showed an interactive effect with occupational exposure to 
low molecular weight agents or irritants on current adult-onset asthma in unexposed (gray) and exposed 
(black) participants.
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could not be applied to our study because our 
gene-selection process aimed to select genes 
potentially associated with the environmental 
exposure because of their biological function. 
We further repeated the analyses using a joint 
test of gene and gene-environment inter action 
(Dai et al. 2012), but similar results were 
obtained (data not shown).
Irritant-induced asthma is typically 
described as a separate, “nonsensitizing,” type 
of occupational asthma (Maestrelli et al. 2009; 
Tarlo and Lemiere 2014). However, low 
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molecular weight agents are generally classi-
fied as sensitizers, although most of them are 
not associated with the production of specific 
immunoglobulin E (IgE) (Tarlo and Lemiere 
2014). The precise mechanisms linking irri-
tants and LMW chemicals to asthma are 
poorly known, and it is therefore challenging 
to classify most asthmogenic chemicals (e.g., 
cleaning products) into definite categories. 
However, occupational exposures to both 
LMW chemicals and irritants may result in 
oxidative stress (Dumas et al. 2015). Thus, we 
could investigate a relatively broad spectrum 
of exposures by carefully selecting genes 
through our pathway-based strategy integrating 
hypotheses about the environment. Smoking 
is also known to be related to oxidative stress. 
Our results remained nearly identical after 
performing analyses excluding current smokers 
or after accounting for smoking, suggesting 
that the detected interactions were not due to 
the effects of smoking.
To our knowledge, none of our findings 
have been reported previously in published 
GWASs of asthma (Hindorff et al. 2015), or in 
GEWIS of asthma. Differences in the lengths 
of microsatellite sequences in the promoter 
region of PLA2G4A were reported between 
patients with severe asthma and healthy 
controls, with a direct impact on mRNA and 
protein expression, suggesting a role in asthma 
pathogenesis (Sokolowska et al. 2010). Few 
candidate G × occupational exposure inter-
action studies have been published for asthma 
(Kauffmann et al. 2010; Kogevinas 2014; 
Smit et al. 2014; Cherry et al. 2015). In a 
GWAS focusing on occupational exposures, 
CTNNA3 (catenin alpha 3, alpha-T catenin) 
was reported to be the strongest candidate gene 
for toluene diisocyanate (TDI)-induced asthma 
in Korean patients (Kim et al. 2009), and only 
one GEWIS has been published that identi-
fied novel susceptibility loci for occupational 
exposure to biological dust, mineral dust, and 
gases and fumes in relation to forced expira-
tory volume in 1 sec (FEV1) levels (de Jong 
et al. 2015).
Interestingly, all of the genes that we 
detected play a role in the NF-κB pathway. 
NF-κB is a ubiquitous transcription factor 
that is involved in the mechanism whereby 
oxidants affect the pathophysiology of asthma 
(Schuliga 2015). The genetic variants inter-
acting with exposure do not belong to protein-
coding regions; rather, they are more likely 
to have a regulatory function, as indicated by 
the functional annotations of a few of these 
SNPs. RELA encodes the RelA protein, 
which is complexed with NFKB1, the most 
abundant form of NF-κB. PRKD1 encodes a 
serine/threonine kinase called PKD1, which 
activates NF-κB in response to oxidative 
stress conditions (Sundram et al. 2011; Storz 
2007). Exposure to a photochemically altered 
air pollutant mixture was associated with a 
decrease in expression of PRKD1 mRNA in 
human lung epithelial cells (Rager et al. 2011). 
In contrast, exposure to zinc oxide nanoparti-
cles, which is associated with acute pulmonary 
oxidative stress and inflammation (Vandebriel 
and De Jong 2012), was reported to activate 
NF-κB in human bronchial epithelial cells 
through a mechanism involving RelA–
NF-κB phosphorylation (Wu et al. 2010). 
Interestingly, in a similar manner, we found 
negative associations between genetic variants 
of PRKD1 and adult-onset asthma (decreased 
risk) and positive associations between genetic 
variants near RELA and adult-onset asthma 
(increased risk) in participants exposed to 
LMW or irritant agents. All of these effects are 
“flip-flop effects,” and we can only speculate 
on the mechanism behind an opposing effect 
among the exposed and unexposed subjects. 
Finally, the protein encoded by PRKCA was 
suggested to be a regulator of NF-κB–induced 
expression of genes involved in inflamma-
tory responses (Nakashima 2002), and it 
was associated with generation of reactive 
oxygen species through a biological interac-
tion with other genes including members 
of the mammalian PLA2 family (Chi et al. 
2014). A role of the secretory phospholipase 
A2 receptor in the development of asthma 
was recently reported in animal models of 
asthma and in human lung cells (Murakami 
et al. 2014; Leslie 2015). It is noteworthy that 
the SNPs interacting with exposure identi-
fied by this study mapped to binding sites on 
proteins including NFKB; histone deacetylase 
2 (HDAC2), whose activity is regulated by 
oxidative stress; and nuclear factor erythroid 
2-related factor 2 (Nrf2), which plays a crucial 
role in the cellular defense against oxidative 
stress. Lastly, chlorine, formaldehyde, and 
hydrogen peroxide were reported to affect 
the localization of the PRKCA protein, 
to modify the expression of PLA2G4A and 
PLA2R1 mRNA, and to modify the activity 
or expression of RELA protein [Comparative 
Toxicogenomics Database (CTD), http://
ctdbase.org/] (Davis et al. 2015). Overall, 
all these data suggest that any or all of these 
genes—PLA2G4A, PLA2R1, RELA, PRKD1, 
and PRKCA—may play a role in the risk of 
asthma in adults in association with exposure 
to LMW agents or irritants.
Conclusions
In conclusion, the present study identified 
new and promising candidate genes inter-
acting with occupational exposures to LMW 
agents or irritants in current adult-onset 
asthma. More generally, this study highlights 
the interest in performing G × E interaction 
analyses to identify new genes and mecha-
nisms of asthma occurrence related to specific 
environmental exposures.
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